Bioinformatics and topological analyses further identified the key targets and pathways modulated by MBP, findings that were subsequently validated via in vitro experiments demonstrating that both MBP and its active compound, naringenin, effectively inhibit melanoma cell proliferation and migration. The gene discussed is MBP; the disease is melanoma.